Skip to main navigation Skip to search Skip to main content

Corrigendum: Baseline neutrophils and derived neutrophilto-lymphocyte ratio: Prognostic relevance in metastatic melanoma patients receiving ipilimumab. [Ann Oncol 27, (2016), (732-738)] doi:10.1093/annonc/mdw016.

  • P. F. Ferrucci
  • , P. A. Ascierto
  • , J. Pigozzo
  • , M. Del Vecchio
  • , M. Maio
  • , G. C.Antonini Cappellini
  • , M. Guidoboni
  • , P. Queirolo
  • , P. Savoia
  • , M. Mandalà
  • , E. Simeone
  • , S. Valpione
  • , M. Altomonte
  • , F. Spagnolo
  • , E. Cocorocchio
  • , S. Gandini
  • , D. Giannarelli
  • , C. Martinoli

Research output: Contribution to journalComment/debate

Abstract

Ann Oncol 2016; 27: 732-738 (doi:10.1093/annonc/mdw016) There is an error in the affiliation of author Jacopo Pigozzo. The correct affiliation is 'Melanoma and Esophageal Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy'.

Original languageEnglish
Pages (from-to)524
Number of pages1
JournalAnnals of Oncology
Volume29
Issue number2
DOIs
Publication statusPublished - 1 Feb 2018

Fingerprint

Dive into the research topics of 'Corrigendum: Baseline neutrophils and derived neutrophilto-lymphocyte ratio: Prognostic relevance in metastatic melanoma patients receiving ipilimumab. [Ann Oncol 27, (2016), (732-738)] doi:10.1093/annonc/mdw016.'. Together they form a unique fingerprint.

Cite this